BMRN - BioMarin Pharmaceutical Non-GAAP EPS of $0.49 beats by $0.04 revenue of $646.2M beats by $8.63M
2024-02-22 16:07:42 ET
More on BioMarin Pharmaceutical
- BioMarin's Growth Potential And Valuation: Is Now The Right Time To Invest?
- BioMarin Pharmaceutical Q4 2023 Earnings Preview
- Paul Singer's Elliott Management adds ETSY, CCI, MTCH; offloads NI, ARM, NE
- Seeking Alpha’s Quant Rating on BioMarin Pharmaceutical
- Historical earnings data for BioMarin Pharmaceutical